Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT00320073 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators